Evaluation of the STANDARD M10 and Xpert

Y Roukoz-Diab, M Ehmig, S Luce, C Eckert, S Timsit, J Couturier, I Mostaghat, F Barbut

Abstract readEvaluation StudyComparative Study

In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Y Roukoz-DiabNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.

M EhmigNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.

S LuceNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.

C EckertDepartment of Clinical Bacteriology, AP-HP, Hôpital Saint-Antoine, Paris, France.

S TimsitNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.ORCID 0009-0003-3508-4558

J CouturierNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.

I MostaghatNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.

F BarbutNational Reference Laboratory for Clostridioides difficile, AP-HP, Hôpital Saint-Antoine, Paris, France.ORCID 0000-0002-4165-0670

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to compare the sensitivity and specificity of two Nucleic Acid Amplification Tests (NAATs), the STANDARD M10

Indexed as

Clostridioides difficileClostridium InfectionsFecesMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesBacterial ProteinsBacterial ToxinsDiarrheaHumansProspective StudiesSensitivity and SpecificityBacterial ProteinsBacterial ToxinsClostridioides difficile infectionCt (cycle threshold) valuesdiagnosisNAATtoxigenic culture

Identifiers

PMID42053306

DOI10.1128/spectrum.03470-25

PMCPMC13227952

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.